The mitochondrion as a primary site of action of regulatory agents involved in neuroimmunomodulation.
A major system of neuroimmunomodulation is the hypothalamic-pituitary-adrenocortical (HPA) axis, acting through glucocorticoids and their intracellular signaling components, exerting both stimulatory and inhibitory effects on the immune reaction. Glucocorticoids inhibit the production of proinflammatory cytokines by interacting with nuclear transcription factors (nuclear factor [NF]-kappaB, activated protein [AP]-1) and induce the production of several anti-inflammatory cytokines by gene activation. In some cells and/or in extreme stress conditions, apoptosis is evoked. In most processes related to neuroimmunomodulation a prominent role is emerging for mitochondria. These organelles generate more than 90% of the cell's energy requirements through oxidative phosphorylation (OXPHOS), which is regulated by several agents, including steroid and thyroid hormones. These hormones are inducers of nuclear and mitochondrial OXPHOS gene transcription and they exert a primary action not only on nuclear but also on mitochondrial genes by way of cognate receptors. Recently, additional nuclear transcription factors involved in neuroimmunomodulation have been detected in mitochondria (NF-kappaB, AP-1, p53, calcium/cAMP response element binding protein [CREB]), and binding sites of these and putative binding sites of other nuclear transcription factors have been identified in the mitochondrial genome. The interaction of these factors with mitochondrial regulatory proteins, with receptors and with the genome has been shown and, in some cases, modulation of mitochondrial transcription was observed with possible effects on energy yield. The mitochondria store a host of critical apoptotic activators and inhibitors in their intermembrane space and the release of these factors could be another possible mode of action of the mitochondrially translocated regulatory agents and receptors.
Psarra
A M G
AM
Foundation for Biomedical Research of the Academy of Greece, Athens, Greece.
Solakidi
S
S
Sekeris
C E
CE
D000818:Animals; D017209:Apoptosis / Q000276:immunology; D006801:Humans; D008928:Mitochondria / Q000276:immunology*; D015213:Neuroimmunomodulation / Q000502:physiology*; D010085:Oxidative Phosphorylation; D011987:Receptors, Steroid / Q000276:immunology; D014157:Transcription Factors / Q000276:immunology
D011987:Receptors, Steroid; D014157:Transcription Factors